Tag : Applications

CCT Impact

South Dakota Department of Health Selects Accela to Power Medical Cannabis Cards and License Applications

CCT IMPACT Agent
Accela, the leading provider of cloud-based solutions for state and local government, today announced that the South Dakota Department of Health will use two components of Accela’s Cannabis Regulation ecosystem to regulate and support the state’s new medical cannabis program. South Dakota began accepting and issuing patient and caregiver card applications......
CCT Impact

Chemistree Investee ImmunoFlex™ Completes Clinical Study and Submits US and International Patent Applications

CCT IMPACT Agent
Chemistree Technology Inc. (CSE: CHM) (CSE: CHM.WT) (OTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to confirm that investee company ImmunoFlex Therapeutics Inc. (“ImmunoFlex”™), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. The exploratory trial was the latest of several small trials where......
CCT Impact

Aion Therapeutic Files 4 New Patent Applications (Including for the Treatment of Human Cancers)

CCT IMPACT Agent
Aion Therapeutic Inc. (CSE: AION) (“Aion Therapeutic” or the “Company“) announced today that it has filed 4 new patent applications related to preparations of medicinal and psychedelic mushrooms. The patent applications include use of medicinal mushrooms for the treatment of human cancers including breast cancer, use of combination medical cannabis and......
CCT Impact

Open Book Extracts Acquires US Patent for Smokable Applications of Terpenoids

CCT IMPACT Agent
Open Book Extracts (OBX) is pleased to announce the purchase of US Patent No. 9,532,593B2 with claims covering the application of terpenoids and cannabinoids onto smokable hemp and other dry herbs. While this intellectual property can be leveraged across multiple sectors and product categories, it is especially compelling for herbal......
CCT Impact

CBD’s Range of Applications Helps Reshape Public Opinion

CCT IMPACT Agent
Cannabis legalization proposals are becoming more popular, and the negative stigma associated with such products is slowly fading away. As Americans head to vote and are very divided ideologically on social and economic issues, there’s something most actually agree on: cannabis legalization. Ahead of the election, 33 states have already......
CCT Impact

Association with Medical Applications Helps Drive Cannabis’ Expansion

CCT IMPACT Agent
Cannabidiol-based (CBD) products’ attribution to various medical applications has prompted a rapid emergence of new products. Yet, despite the increase in popularity, the FDA has only approved one cannabis-based drug, Epidolex, which is used to treat epilepsy. Nevertheless, thousands of retailers and e-commerce platforms begun to sell CBD products after......